瓦莫罗隆:一种新型的耐新陈代谢类固醇,可以抑制慢性多关节炎的关节破坏,并减少全身副作用
Ana Crastin1, Arjan Shanker1, Michael S Sagmeister2
1Department of Biomedical Sciences, University of Birmingham, Birmingham, UK.
Rheumatology (Oxford, England)
|April 1, 2025
概括
瓦莫罗隆是一种新型类固醇,其抗炎作用与普雷迪尼索隆相似,但副作用较少. 它在治疗多关节炎中的有效性独立于11β-HSD1代谢.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 免疫学和炎症 免疫学和炎症
背景情况:
- 葡萄糖皮质类药物是炎症性疾病的标准治疗方法,但会引起显著的副作用.
- 瓦莫罗隆是一种类固醇化合物,旨在减少与葡萄糖皮质类药物相关的不良影响.
- 11β-hydroxysteroid脱酶1型 (11β-HSD1) 是葡萄糖皮质体代谢中的一个关键酶.
研究的目的:
- 为了研究瓦莫罗龙对11β-HSD1代谢的抗性.
- 在多关节炎的小鼠模型中评估vamorolone的治疗疗效和安全性.
- 为了比较vamorolone与普得尼索隆的效果,一种标准的葡萄糖皮质体治疗.
主要方法:
- 在体外评估瓦莫罗龙的11β-HSD1代谢.
- 给野生型和11β-HSD1淘汰 (TNFtg11BKOKO) 患有多关节炎的小鼠服用瓦摩洛,普雷尼索隆或载体.
- 每天监测疾病严重程度和每日体重,并对炎症,关节破坏和副作用进行终点评估.
主要成果:
- 瓦莫洛隆在体外完全抵抗11β-HSD1代谢.
- 瓦莫罗隆在减少关节炎症,血清IL-6和突炎方面表现出与普雷迪尼索隆相似的抗炎疗效.
- 瓦莫洛隆治疗没有诱导典型的葡萄糖皮质类药物副作用,如上腺缩,体重减轻,肌肉衰竭或合成代谢骨抑制.
结论:
- 与有效剂量的普得尼索隆相比,瓦莫洛隆表现出强大的抗炎活性,系统性副作用概况降低.
- 瓦摩洛的治疗效益在很大程度上独立于11β-HSD1代谢.
- 瓦莫罗隆在治疗炎症方面具有前景,但在较高剂量下其安全性需要进一步研究.
关键词:
骨质损失导致骨质损失.葡萄糖皮质类药物肌肉消耗 肌肉消耗 肌肉消耗多关节炎是一种多关节炎.普雷迪尼索隆 (prednisolone) 是一种药物.类风湿性关节炎 类风湿性关节炎类固醇代谢的代谢 类固醇代谢您可以使用vamoroloneone.更多相关视频
03:07Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
Published on: July 12, 2024
794
14:49Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
41.7K
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
91
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
91
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
109
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
109
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
103
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
103
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
160
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
160
01:15Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
01:19Antiasthma Drugs: Leukotriene Modifiers
180
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
180